daphne quimi  amicus therapeutics inc  zoominfocom bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version fold daphne e quimi insider trades for amicus therapeutics inc bulletin merck profit and sales top expectations amid big jump in keytruda sales » investor alert new york markets open in market snapshot analyst ratings expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close amicus therapeutics inc nasdaq fold go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus amicus therapeutics inc after hours  quotes are delayed by  min jul    pm fold quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   insider activity individual daphne e quimi ms daphne e quimi is senior vice presidentfinance  administration at amicus therapeutics inc a member at institute of management accountants inc and a member at the american institute of certified public accountants she received her undergraduate degree from monmouth university and an mba from new york university transactions date shares transaction value     award at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      award at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      acquisition at  per share      disposition at  per share      acquisition at  per share      disposition at  per share      acquisition at  per share      award at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives mr john francis crowley chairman  chief executive officer mr bradley l campbell president  chief operating officer mr william d baird chief financial officer dr jay a barth chief medical officer dr hung do chief scientific officer dr enrique dilone senior vice presidenttechnical operations ms daphne e quimi senior vice presidentfinance  administration mr dipal doshi chief business officer mr jeffrey p castelli svpprogram management  portfolio planning ms jayne c gershkowitz chief patient advocate dr kenneth j valenzano senior vice presidentpreclinical research mr patrik s florencio chief compliance officer mr willem w van weperen regional vice president mr david allsopp senior vice presidentinternational mr mark baldry vice presidentglobal marketing ms sara pellegrino headinvestor  media relations mr kurt j w andrews senior vice presidenthuman resources ms ellen stacy rosenberg secretary  general counsel dr andrew e mulberg vice presidentregulatory strategy mr john r kirk vice presidentregulatory affairs mr craig a wheeler independent director mr glenn p sblendorio independent director mr donald j hayden lead independent director mr robert a essner independent director dr ted w love independent director mr michael g raab independent director ms margaret g mcglynn independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest acan snap fall even more as lockups expire achip stocks are cool again but reality is here awhere to get chipotle queso check out this interactive map aaarons acquires its largest franchisee in allcash deal aexpedia stock price target raised to  from  at piper jaffray aa provocative new analysis suggests you don’t have to take all your antibiotics after all aa case for buying the freakin’ dip with amazon as the mooch might now say apriceline stock price target raised to  from  at piper jaffray asjw group upgraded to buy from neutral at janney avf corp stock price target raised to  from  at susquehanna financial adollar spins wheels ahead of gdp report expected to show faster clip of growth avf corp upgraded to positive from neutral at susquehanna financial ateradyne upgraded to overweight from sector weight at keybanc capital alogmein upgraded to overweight from sector weight at keybanc capital atwitter stock price target raised to  from  at rbc capital acocacola zero sugar sparks analyst optimism but other factors could stifle growth aintel stock price target raised to  from  at suntrust rh amastercard stock price target raised to  from  at suntrust rh acharter communications stock price target raised to  from  at suntrust rh awhy the gdp report may show us economy growing twice as fast loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  reuterscom x edition united states africa américa latina عربي argentina brasil canada  deutschland españa france india italia  méxico россия united kingdom united states people amicus therapeutics inc foldo related topics stocksstock screenerhealthcarepharmaceuticals overview news key developments people charts financials analysts research pulse foldo on consolidated issue listed on nasdaq global market usd  jul  change  chg   prev close  open  days high  days low  volume  avg vol  wk high  wk low  quimi daphne  ms daphne e quimi serves as senior vice president  finance and administration corporate controller of amicus therapeutics inc prior to amicus ms quimi served as director of consolidations and external reporting at bristolmyers squibb she also held roles of increasing responsibility in the finance department at johnson  johnson ms quimi brings extensive experience in public accounting and financial reporting ms quimi received a bs in accountancy from monmouth university and an mba from the stern school of business of new york university she is a certified public accountant in new jersey and a member of the american institute of certified public accountants and the institute of management accountants basic compensation total annual compensation usd  restricted stock awards usd  longterm incentive plans usd  all other usd  fiscal year total usd  options compensation   quantity market value exercisable   unexercisable   exercised   basic compensation name fiscal year total john crowley  bradley campbell  william baird  daphne quimi  kurt andrews  hung do  as of   dec  » view all officers related topics stocksstock screenerhealthcarepharmaceuticals daphne e quimi  executive bio compensation history and contacts  equilar atlas   log in  sign up x   as featured in daphne e quimi corporate controller at amicus therapeutics inc view full profile are you daphne e quimi claim your profile   sign up for equilar atlas and view daphne e quimis full profile with equilar atlas you can identify corporate executives in daphne e quimis network and community follow changes in daphne e quimis employment and moneyinmotion connect with daphne e quimi through your network of contacts daphne e quimis executive work history current corporate controller amicus therapeutics inc past to view daphne e quimis complete executive work history sign up now age      daphne e quimis biography daphne quimi  has served as corporate controller since january  and prior thereto as director of accounting policy and external reporting since september  from october  to september  ms quimi worked at bristolmyers squibb company where she served as director of consolidations and external reporting ms quimi is a certified public accountant in new jersey and a member of the american institute of certified public accountants and the institute of management accountants ms quimi received a bs in accountancy from monmouth university and an mba from the stern school of business of new york university source amicus therapeutics inc on    sign up for equilar atlas and view daphne e quimis full profile by accessing equilar atlas you can view bios network salary and wealth events of industryleading executives like daphne e quimi more specifically youll be able to identify corporate executives in daphne e quimis network and community follow changes in daphne e quimis employment and moneyinmotion connect with daphne e quimi through your network of conections view full profile   search for over  executive profiles bio example daphne e quimi daphne e quimis connections  sign up now to view daphne e quimis  connections » s nicole o schaeffer senior vice president human resources and corporate services insmed incorporated david j lockhart former chief scientific officer amicus therapeutics inc ted w love dir president and chief executive officer global blood therapeutics inc joan c winterbottom former vice president and chief human resources officer argos therapeutics inc william d baird chief financial officer amicus therapeutics inc margaret g mcglynn board member air products john f crowley chairman of the board and chief executive officer amicus therapeutics inc kenneth w peist former vice president legal and intellectual property amicus therapeutics inc craig a wheeler dir president and chief executive officer momenta pharmaceuticals inc m james barrett chairman of the board proteostasis therapeutics inc popular profiles sign up now to view more executive profiles » thomas j lynch executive chairman te connectivity ltd john j kita evp and cfo a o smith carl g annessa evp and coo hornbeck offshore services inc elon r musk ceo and chairman tesla michael c montgomery board member nmi holdings inc × claim your profile coming soon interested in updating your biography and work history were working on making it happen well email you when this feature is available please enter valid email address done thank you for your interest ok browse executive profiles  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z equilar homepage equilar atlas equilar insight equilar boardedge equilar engage research services knowledge network about us login ï¿½  equilar all rights reserved privacy policy  marshall street redwood city ca   phone    fax   ﻿ daphne quimi unloaded  shares of amicus therapeutics inc nasdaqfold in an insider trade – octafinance friday  july  menu featured news  years ago  alphabet inc nasdaqgoogl tests its ad technology on billboards to cushion itself against ad blocks  years ago  china margin debt hits week high japan pumps’n’dumps as kyle bass fears looming em banking crisis  years ago  marc faber shares his insight in one hour exclusive interview he covers all from commodities and china to inflation the euro and gold  years ago  carl icahn criticizes the fed feels bad for investors buying junk bonds  years ago  john burbank european qe can’t save the markets same as the us quantitative easing everything will be liquidated daphne quimi unloaded  shares of amicus therapeutics inc nasdaqfold in an insider trade  by octastaff in insider news momentum equities share with your friendsyour nameyour emailrecipient emailenter a messagei read this article and found it very interesting thought it might be interesting for you the article is called daphne quimi unloaded  shares of amicus therapeutics inc nasdaqfold in an insider trade and is was published by octafinancecom at httpwwwoctafinancecomdaphnequimiunloadedsharesofamicustherapeuticsincnasdaqfoldinaninsidertradecaptchasubmit daphne quimi insider sell transaction daphne quimi is the vice president finance of amicus therapeutics inc nasdaqfold    she a few days ago sold  shares in the public firm with the transaction value totalling exactly  us dollars this is based on the transaction provided price of  per share this is not her first insider trade in the last  days she unloaded another  shares worth  usd currently mr daphne has  shares which accounts for  of the company’s market capitalization amicus therapeutics inc stock rating sentiment and fundamentals it is difficult to make conclusions about amicus therapeutics inc’s future just from daphne quimi’s sale because in this filing the insider also revealed option transactions in the form it was reported that daphne exercised options for  shares with average price  worth  the five leading equity analysts that cover the corporation financial position forecast  earningspershare for  which gives amicus therapeutics inc priceearnings ratio of nan rating  sentimentpsychsignal socialsellanalysts ratingbuyhedge funds sentimentbuy stock fundamentalsearnings  fcf trendsellsectorindustry macrobullishvaluation models technical analysisst trenddownmt trenddownlt trenddown octafinance ratingsell  read how our stock ratings system works chart analysis shows amicus therapeutics inc’s share price dived  in the last  days and this downward trend looks set to continue we too rate the listed company’s stock a sell mainly because of our equities trendfollowing model which is displayed below price chart of amicus therapeutics nasdaqfold stock source rightedgesystems yahoo split  dividend adjusted data and octafinance interpretations legendary stock traders who also include paul tudor jones once shared that the highest returns are made when technical  fundamental analysis are combined hedge funds ownership in the last quarter  hedge funds and institutional investors owned amicus therapeutics inc the institutional ownership of the firm in q  is high at  of the shares outstanding they increased by  million the total shares they hold as of that quarter these investment managers owned  million shares a total of  funds opened new positions in amicus therapeutics inc and  increased their holdings there were  funds that closed their positions and  that reduced them as published by sec’s f filings the firm is in top  stock holdings of six funds some of them are longwood capital partners llc perceptive advisors llc venbio select advisor llc redmile group llc eam investors llc apis capital advisors llc longwood capital partners llc had the greatest investment with ownership of  million shares as of q  for  of the fund’s portfolio joseph edelman’s perceptive advisors llc is another positive institutional investor owning  million shares of the company or  of their stocks portfolio the stock is also  of the fund’s aum the californiabased fund venbio select advisor llc have  of their stock portfolio invested in the stock for  million shares further jeremy green’s redmile group llc disclosed it had acquired a stake worth  of the fund’s stock portfolio in the company the californiabased fund eam investors llc was also a notable believer in the firm possessing  shares amicus therapeutics inc is  of the fund’s stock portfolio amicus therapeutics nasdaqfold company profile amicus therapeutics inc is a biopharmaceutical company the company focuses on the discovery development and commercialization of medicines for a range of rare and orphan diseases with a focus on improved therapies for lysosomal storage disorders sds the company’s lead product candidate is the pharmacological chaperone migalastat hcl galafold a small molecule that can be used as a monotherapy and in combination with enzyme replacement therapy ert for fabry disease the company’s development programs also include erts for lsds including fabry disease pompe disease and mucopolysaccharidosis type i mps i the company’s programs in development include the small molecule pharmacological chaperone migalastat as a monotherapy for fabry disease sd for epidermolysis bullosa eb as well as ert products for fabry disease pompe disease and mps i company website amicus therapeutics amicus therapeutics inc was founded in delaware on  the firm has  employees as of writing its market capitalization is  million and it has  million shares outstanding at the moment there are  shareholders and the institutional ownership is  the stock closed at  yesterday and it had average  days volume of  shares it is up from the  days average shares volume of  amicus therapeutics inc has a one year low of  and a  days high of  the current price is below the  days sma  the exercise of stock options and subsequent sale of common stock were made pursuant to a rule b trading plan adopted by the reporting person on december  –   this price is the weighted average purchase price for the transactions reported on this line the prices for the transactions reported on this line range from  to  the reporting person undertakes to provide – upon request – by the staff of the securities and exchange commission – the issuer – or a security holder of the issuer – full information regarding the number of shares purchased at each separate price  this price is the weighted average sale price for the transactions reported on this line the prices for the transactions reported on this line range from  to  the reporting person undertakes to provide – upon request – by the staff of the securities and exchange commission – the issuer – or a security holder of the issuer – full information regarding the number of shares sold at each separate price amicus therapeutics  receive news  ratings via email  enter your email address below to receive a concise daily summary of the latest news and analysts ratings with marketbeatcoms free daily email newsletter tagged amicus therapeutics  nasdaqfolddaphne quimi hanesbrands inc nysehbi hedge funds sentiment kenneth peist amicus therapeutics inc nasdaqfold’s insider sold  shares amicus therapeutics  get news  ratings daily enter your email address below to get the latest news and analysts ratings for amicus therapeutics with our free daily email newsletter hedge fund newstop  citadel advisors f holdings in q df dent  co inc just released its q  stock positionsmaverick capital top  holdings in q analyzing ken griffins citadel advisors stock holdings in q lone pine capital top  f positions in q guru newsfelix zulauf sees a stock market correction coming this rally sp  indexspinx will be shortlivedmarc faber shares his insight in one hour exclusive interview he covers all from commodities and china to inflation the euro and goldjim grant the next thing might be helicopter money what to buy and where he sees investment opportunitieskyle bass bearish on emerging markets for at least  more years looking to short currenciesdavid tepper gets defensive is it time to get out of the stock market macro newschina margin debt hits week high japan pumps’n’dumps as kyle bass fears looming em banking crisisare us – russian relations a zerosum gameus and russia have launched direct talks on the conflict in syriayuan drops as pboc cuts reference rate by most since devaluationcould the market crash like —put volume spike argues low is nearctas newsred rock just published report about the trend following landscape  how ctas’ performance must be analyzedhow to implement dual momentum for nonus investorsdo commodity trading advisors ctas really provide crisis alpha equity hedge and are long volatility daphne e quimi  senior vice president finance  corporate controller at amicus therapeutics inc news home advertising board and executive moves energy health care hedge funds m  a private equity technology you have    free profiles   left this month    start your free trial ➤ hey we noticed youre a relsci pro subscriber would you like to view the page there view on relsci pro ➤ email linkedin facebook google tweet reddit permalink daphne e quimi senior vice president finance  corporate controller at amicus therapeutics inc overview relationships paths education memberships career history public holdings transactions awards  honors daphne e quimi senior vice president finance  corporate controller at amicus therapeutics inc overview age  born  awards  number of relationships this person is connected to  people relationships see details john f crowley chief executive officer at amicus therapeutics inc donald j hayden jr senior vice president at e r squibb  sons interamerican corp geoffrey p gilmore general counsel at agile therapeutics inc bradley l campbell former president  chief operating officer at amicus therapeutics inc matthew r patterson cofounder at audentes therapeutics inc enrique dilone senior vice president technical operations at amicus therapeutics inc jayne c gershkowitz former senior vice president patient  professional advocacy  public policy at amicus therapeutics inc jeffrey p castelli senior vice presidentprogram management  portfolio planning at amicus therapeutics inc jayne gerskowitz senior vice president patient  professional advocacy  public policy at amicus therapeutics inc william d baird iii former chief financial officer  secretary at amicus therapeutics inc see  more listings with relsci professional start my free trial ➤ see  more paths to daphne e quimi daphne e quimi you connections via relationship science daphne e quimi sync your contacts to see how you can connect with daphne e quimi start my free trial ➤ see more educational background bs in accountancy  monmouth university monmouth university is a leading private institution that offers a comprehensive array of undergraduate and graduate degree programs the university provides students with a highly personalized education that builds the knowledge and confidence of tomorrows leaders located in west long branch new jersey monmouth universitys magnificent and historic campus is approximately one hour from both new york city and philadelphia and is within walking distance of the beaches of the atlantic ocean learn more about what makes monmouth a unique fullspectrum institution of higher education mba  new york university  leonard n stern school of business since its inception in  new york university stern school of business has been in and of new york city founded as the school of commerce finance and accounting the school initially offered training to students for careers in commerce in the burgeoning financial markets of new york city today located in the heart of greenwich village with a campus in westchester stern is one of the nation’s premier management education schools and research centers with a broad portfolio of academic programs at the graduate and undergraduate levels with its global partnerships and engagement in nyu’s global network university today nyu stern is not only in and of the city but also in and of the world memberships member current american institute of certified public accountants the american institute of certified public accountants provides vocational education in accounting the company provides services to the accounting community regulatory bodies and other organizations it also operates in jersey city washington and lewisville it was founded in  and is headquartered in new york city ny member current institute of management accountants to provide a forum for research practice development education knowledge sharing and the advocacy of the highest ethical and best business practices in management accounting and finance career history senior vice president finance  corporate controller   current amicus therapeutics inc amicus therapeutics inc is a biotechnology company which is engaged in the discovery development and commercialization of novel treatments for patients living with rare and orphan diseases its product include migalastat hcl which is a small molecule that can be used as a monotherapy and in combination with enzyme replacement therapy for fabry disease the company was founded on february   and is headquartered in cranbury nj directorconsolidations  external reporting    bristolmyers squibb company bristolmyers squibb company our company has a strong legacy of innovation that began in new york in  when edward r squibb md founded a pharmaceutical company in brooklyn and in  when two friends william mclaren bristol and john ripley myers purchased a struggling drug manufacturing firm in clinton together they laid the foundation for our company today — a global biopharma leader that continues this legacy of innovation public holdings restricted data only for relsci professional users start my free trial ➤ see more transactions details hidden amicus therapeutics inc raised money in a private placement transaction details hidden amicus therapeutics inc raised money in a private placement transaction details hidden amicus therapeutics inc raised money in a private placement transaction details hidden amicus therapeutics inc raised money in a private placement transaction awards  honors professional certification cpa certified public accountant sponsored by american institute of certified public accountants other affiliations daphne e quimi is affiliated with amicus therapeutics inc bristolmyers squibb company youve reached your  free profiles limit this month upgrade to relsci pro today to enjoy unlimited article views and much more start my free trial ➤ still not convinced check out our full listing of features here are you a relsci pro subscriber login to relsci pro  ➤ not a pro subscriber log in here to manage your alerts keep me signed in login  ➤ forgot your password i have read the lexisnexis terms  conditions sign me up  ➤